Peculiarities of the course of non-small cell lung cancer and the percentage / of lymphocytes in blood of patients considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment

The issue of the peculiarities of the course of the malignant process and the informative value of hematological parameters in patients with non-small cell lung cancer (LC) considering gender specific difference, upon COVID-19 before the beginning of antitumor treatment, has been poorly studied.